Dahl Andrew M. bought EW
May 7, 2026 · Form 4 insider transaction
Dahl Andrew M. bought 6,745 shares of Edwards Lifesciences Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,745
Price
$0.00
Total value
N/A
InsiderDahl Andrew M.
Role—
SecurityEmployee Stock Option (Right to Acquire)
Transaction codeA: Grant or award
Transaction dateMay 7, 2026
Filing dateMay 8, 2026
Shares owned after6,745
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.